TOMMY PRICE: Open Payments
NPI 1508435298 · SEBRING, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,182 in 194 payments from 36 companies in 2025. Trend: 2023 $3,552 · 2024 $3,950 · 2025 $4,182
Food & beverage: $4,034Education: $148
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $455 |
| AstraZeneca Pharmaceuticals LP | 12 | $299 |
| Celgene Corporation | 10 | $284 |
| PFIZER INC. | 20 | $281 |
| Daiichi Sankyo Inc. | 8 | $226 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $220 |
| Incyte Corporation | 9 | $210 |
| Ipsen Biopharmaceuticals, Inc | 4 | $196 |
| Novartis Pharmaceuticals Corporation | 13 | $186 |
| E.R. Squibb & Sons, L.L.C. | 9 | $180 |
Products named: Enhertu, REBLOZYL, RYBREVANT, OPDIVO, Nubeqa, LIBTAYO, JAKAFI, Korlym.
Industry payments across FL — which companies pay providers there.
